tiprankstipranks

Jennifer E. Cook Insider Profile

4 Followers
Jennifer E. Cook, Director at Denali Therapeutics, holds 6.89K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 15.53K shares in Denali Therapeutics (Ticker: DNLI), holds 7.15K shares in BridgeBio Pharma (Ticker: BBIO). Most recently, Jennifer E. Cook Sold ― shares of Jazz Pharmaceuticals on Dec 06, 2023 for an estimated value of 49.74K.
tipranks
Jennifer E. Cook

Jennifer E. Cook
Denali Therapeutics (DNLI)
Director

Ranked #26,647 out of 98,743 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+8.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
62.46%
21.34%
16.21%
A breakdown of Jennifer E. Cook's holdings

Insider Roles

Jazz Pharmaceuticals
(JAZZ)
Director
Denali Therapeutics
(DNLI)
Director
BridgeBio Pharma
(BBIO)
Director
Roles that Jennifer E. Cook holds in companies

Most Profitable Insider Trade

Stock:
Jazz Pharmaceuticals
(JAZZ)
Rating:Informative Sell
Date:Aug 15, 2023 - Today
Return:+21.40%
The most profitable trade made by Jennifer E. Cook

Jennifer E. Cook's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Denali Therapeutics
Jun 05, 2023
Director
Uninformative Buy
$261.66K
BridgeBio Pharma
Feb 21, 2023
Director
Uninformative Buy
$198.75K
Jazz Pharmaceuticals
Dec 06, 2023
Director
Informative Sell
49.74K
$766.01K
List of latest transactions for each holding click on a transaction to see Jennifer E. Cook's performance on stock

Jennifer E. Cook insider profile FAQ

What is the percentage of profitable transactions made by Jennifer E. Cook?
The percentage of profitable transactions made by Jennifer E. Cook is 80%.
    What is the average return per transaction made by Jennifer E. Cook?
    The average return per transaction made by Jennifer E. Cook is 8.20%.
      What stocks does Jennifer E. Cook hold?
      Jennifer E. Cook holds: DNLI, BBIO, JAZZ stocks.
        What was Jennifer E. Cook’s latest transaction?
        Jennifer E. Cook latest transaction was an Informative Sell of $49.74K.
          What was Jennifer E. Cook's most profitable transaction?
          Jennifer E. Cook’s most profitable transaction was an Informative Sell of JAZZ stock on August 15, 2023. The return on the trade was 21.40%.
            What is Jennifer E. Cook's role in Denali Therapeutics?
            Jennifer E. Cook's role in Denali Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.